Francesco Moccia Selected Research

Francesco Moccia Research Topics

Disease

18	Neoplasms (Cancer) 04/2021 - 11/2011
4	Primary Myelofibrosis (Myelosclerosis) 01/2020 - 01/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2015
2	Heart Diseases (Heart Disease) 01/2022 - 01/2022
2	Cognitive Dysfunction 01/2022 - 06/2021
2	Glioma (Gliomas) 04/2021 - 04/2021
2	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 10/2018
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2017
2	COVID-19 01/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 04/2019
2	Cardiomyopathies (Cardiomyopathy) 08/2019 - 12/2018
2	Infections 02/2019 - 01/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2018 - 02/2014
2	Carcinoma (Carcinomatosis) 02/2016 - 01/2012
2	Gastroesophageal Reflux (GERD) 01/2014 - 01/2013
2	Hiatal Hernia 01/2013 - 03/2009
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Dementia (Dementias) 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Scleroatonic muscular dystrophy 12/2021
1	Bethlem myopathy 12/2021
1	Hemorrhage 12/2021
1	Neuroblastoma 04/2021
1	Hypertrophy 01/2021
1	Cardiotoxicity 01/2021
1	Myocardial Infarction 01/2021
1	Reperfusion Injury 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Essential Thrombocythemia 01/2020
1	Gliosis 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2020
1	Malignant Mesothelioma 11/2019
1	Mesothelioma 11/2019
1	Vascular Remodeling 01/2019
1	Hypercholesterolemia 01/2019
1	Congenital Heart Defects (Congenital Heart Defect) 12/2018
1	Kidney Neoplasms (Kidney Cancer) 12/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2018
1	Fibrosis (Cirrhosis) 09/2018
1	Lymphoma (Lymphomas) 01/2017
1	Hemangioma (Angioma) 02/2016
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Epilepsy (Aura) 01/2015

Drug/Important Bio-Agent (IBA)

10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2011
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	Two-Pore ChannelsIBA 01/2021 - 12/2018
4	CalciumIBA 01/2020 - 11/2011
4	erucylphosphocholineIBA 09/2015 - 01/2012
3	NAADP (nicotinic acid adenine dinucleotide phosphate)IBA 01/2022 - 12/2018
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2020 - 11/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 02/2014
2	Ion Channels (Ion Channel)IBA 01/2022 - 11/2019
2	CollagenIBA 12/2021 - 09/2018
2	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 04/2021
2	CalreticulinIBA 01/2020 - 01/2020
2	Transient Receptor Potential ChannelsIBA 01/2019 - 02/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2016 - 01/2013
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2016 - 09/2015
1	Purinergic Receptors (Receptors, Purine)IBA 06/2021
1	Neuroprotective AgentsIBA 06/2021
1	Liposomes (Liposome)IBA 06/2021
1	Pt(O,O'-acac)(gamma-acac)(DMS)IBA 04/2021
1	Platinum Compounds (Compounds, Platinum)IBA 04/2021
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	CalcineurinIBA 01/2020
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	AsbestosIBA 11/2019
1	IonsIBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2019
1	Local Anti-Infective Agents (Antiseptics)IBA 02/2019
1	ChemokinesIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Polychlorinated Biphenyls (PCBs)IBA 12/2018
1	MTOR InhibitorsIBA 12/2018
1	Angiogenesis InhibitorsIBA 12/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2018
1	Sphingosine-1-Phosphate ReceptorsIBA 10/2018
1	sphingosine kinaseIBA 10/2018
1	PhosphatidylglycerolsIBA 09/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2018
1	Surface-Active Agents (Surfactants)IBA 09/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2018
1	Complex MixturesIBA 09/2018
1	phosphatidylethanolamineIBA 09/2018
1	beractant (Survanta)FDA Link 09/2018
1	indium-bleomycinIBA 09/2018
1	Cyclic ADP-Ribose (cADPR)IBA 01/2017
1	MitogensIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017

Therapy/Procedure

9	Therapeutics 11/2019 - 11/2011
3	Fundoplication 01/2014 - 03/2009
1	Drug Therapy (Chemotherapy) 04/2021
1	Gastrectomy 01/2014